Emergent BioSolutions (EBS) Approves $35M Buyback
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Join SI Premium – FREE
Emergent BioSolutions Inc. (NYSE: EBS) has authorized the repurchase of up to $35 million of the company’s common stock from time to time on the open market or in privately negotiated transactions.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Reinstates Emergent BioSolutions (EBS) at Underweight
- Cosmos Health posts 29% revenue rise in Q2 but net loss widens
- Havas repurchases shares under its €50M buyback program
Create E-mail Alert Related Categories
Stock BuybacksSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
